Molecular epigenetic targets for liver diseases: current challenges and future prospects
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference115 articles.
1. Epigenetics in liver disease;Mann;Hepatology,2014
2. MicroRNAs and other non-coding RNAs as targets for anticancer drug development;Ling;Nat. Rev. Drug Discov.,2013
3. Epigenetic modifications as new targets for liver disease therapies;Zeybel;J. Hepatol.,2013
4. Prospects for the development of epigenetic drugs for CNS conditions;Szyf;Nat. Rev. Drug Discov.,2015
5. Cancer epigenetics drug discovery and development: the challenge of hitting the mark;Campbell;J. Clin. Invest.,2014
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of CSTF2 in cancer: from technology to clinical application;Cell Cycle;2024-01-02
2. Targeting epigenetic modifications in Parkinson's disease therapy;Medicinal Research Reviews;2023-04-29
3. Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease;Frontiers in Pharmacology;2021-11-23
4. Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells;Food and Chemical Toxicology;2020-02
5. lncRNA AK054386 Functions as a ceRNA to Sequester miR-199 and Induce Sustained Endoplasmic Reticulum Stress in Hepatic Reperfusion Injury;Oxidative Medicine and Cellular Longevity;2019-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3